BioSpace News Archive

Business

Daxor Corporation Appoints Kathryn A. Kornafel Vice President of Marketing and Commercial Development

Daxor Corporation announces the appointment of Kathryn A. Kornafel as vice president of Marketing and Commercial Development.

July 5, 2018
·
3 min read
FDA

Wright Medical Group N.V. Announces FDA Premarket Approval for AUGMENT® Injectable Bone Graft

Clinically Proven, Cost-Effective, Injectable Formulation of AUGMENT® Approved in U.S. for Ankle and/or Hindfoot Fusion

July 5, 2018
·
6 min read
Drug Development

Actinium Pharmaceuticals Announces Treatment of First Patient in Novel Combination Trial of Actimab-A Plus CLAG-M

Trial supports Actinium’s strategic expansion of its CD33 program into novel combinations that can lead to increased use of bone marrow transplants and expand the addressable patient population for this program

July 5, 2018
·
6 min read
Business

Catalyst Pharmaceuticals Appoints Daniel J. Brennan as Chief Commercial Officer

Catalyst Pharmaceuticals, Inc. announced the appointment of Daniel J. Brennan as Chief Commercial Officer.

July 5, 2018
·
4 min read
Drug Development

New England Journal of Medicine Publishes Novavax’ NanoFlu Clinical Trial Data

NanoFlu Phase 1/2 trial data published in a peer-reviewed letter to the editor in The New England Journal of Medicine

July 5, 2018
·
4 min read
Business

Elite Pharmaceuticals, Inc. Announces Passing of Board Member Eugene Pfeifer

Elite Pharmaceuticals, Inc. announced that a member of its Board of Directors, Eugene Pfeifer, passed away on Sunday, June 10, 2018.

July 5, 2018
·
3 min read
Deals

Orion Biotechnology Canada Acquires K2Biomedical

Orion Biotechnology Canada Ltd. announced the acquisition of K2Biomedical

July 5, 2018
·
2 min read
Business

Elite Pharmaceuticals, Inc. Reports Financial Results for the Fiscal Year Ended March 31, 2018 and Provides Conference Call InformationConference Call Scheduled for Friday, June 15 at 1:00 PM EDT

Elite Pharmaceuticals, Inc. announced results for the fiscal year ended March 31, 2018

July 5, 2018
·
4 min read
Drug Development

ERYTECH to Present Preclinical and Clinical Data on Use of Eryaspase in ALL and AML at EHA 2018

ERYTECH Pharma announced that it will present preclinical data on the enzymatic activity of eryaspase (GRASPA®) at the European Hematology Association (EHA) Congress

July 5, 2018
·
8 min read
Deals

Cryo-Cell Consummates Acquisition of CORD:USE Assets and Extends Its Leadership Position Into the Public Cord Blood Banking Arena

Cryo-Cell International, Inc. announced that it has completed its acquisition of substantially all of the assets of CORD:USE Cord Blood Bank, Inc.

July 5, 2018
·
4 min read